ADORA2A and neoplasm: Moreover, CAF capacity to elevate cortisol modestly, block A2A adenosine receptors, and boost T-cell and natural killer cell activity has demonstrated tumor-protective effects in vivo, suggesting possible synergy with immunotherapeutic regimens.